Zofia Jordan is currently an independent consultant for Compound Compliance, formerly she was Compound Compliance specialist for discovery compounds at GSK, where she has proven experience in managing both the physical handling and associated data around controlled compounds. As the Chair of the Controlled Substance Compliance Expert Community, Pistoia Alliance, she represented Pharma in talks with the Advisory Council on Misuse of Drugs to modify the Third Generation Synthetic Cannabinoid amendment, which finally came into law in November 2019, releasing thousands of compounds back into discovery libraries across pharma.